comprehensive -WSS

comprehensive

author：hotspot 2025-08-31 13:10:21 - browse：679

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

WSS

Covid silver lining: Unprecedented look at human immune system

Dairy farmers resist CDC push for PPE against bird flu virus

Oral obesity drug from Viking Therapeutics hits key early target

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Readout LOUD podcast: What to know about H5N1 bird flu

Sanofi strikes deal with Novavax, boosting the vaccine maker

leisure time

comprehensive

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Insurer loopholes limit power of law against surprise medical bills

Anesthesiologist group: stop taking Ozempic before surgery

Scientists uncover potential path to treating deadly childhood tumor

23andMe had bad news about my health. I wish a person had delivered it

H5N1 communication has been strictly for the birds

Cancer drug shortages should be causing more outrage

Researchers on aging grapple with how to calculate biological age

Alkermes shareholders re

Trial using CRISPR to edit HIV out of cells disappoints

explore

Study: Adult vaccinations pay for themselves in societal benefits

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Trial using CRISPR to edit HIV out of cells disappoints

Gut bacteria may contribute to kidney autoimmunity, study finds

Sanofi strikes deal with Novavax, boosting the vaccine maker

Study: Black kids more likely to die after surgery than white kids

focus

focus

knowledge

focus